Contact Us
Search:
Our CompanyPartnershipsProductsContract ManufacturingInvestor Relations

    Brimonidine Tartrate


Advancing the New Vision
Injectables
Ophthalmics
Specialty Therapeutics
    PRODUCT INFORMATION

Brimonidine Tartrate
17478-715-11 - Brimonidine Tartrate Ophthalmic Solution

NDC: 17478-715-11
Product Description: Brimonidine Tartrate Ophthalmic Solution

Description: 0.2% Sterile Ophthalmic Solution

Compare to: AlphaganŽ by Allergan

Size: 10 mL     

Unit of Sale: 1

Type: Rx           Orange Book: AT
NDC AMERISOURCE BERGEN BRUNSWIG CARDINAL MCKESSON MORRIS DICKSON
17478-715-11 4968749 562-095 3772514 1837723 


Qty

Each mL contains:

Active: Brimonidine Tartrate 2 mg (equivalent to 1.32 mg as Brimonidine free base);

Preservative: Benzalkonium Chloride (0.05 mg);

Inactives: Citric Acid, Polyvinyl Alcohol, Sodium Chloride, Sodium Citrate; Hydrochloric Acid and/or Sodium Hydroxide may be added to adjust pH (5.6 to 6.6) and Water for Injection.

Complete Sell Sheet
Material Safety Data Sheet
Package Insert



DISCLAIMER
All labeling reflected on this website is for informational and promotional purposes only. It is not intended to be used by healthcare professionals or patients for the purpose of prescribing or administering these products. Questions regarding the current content of product labeling should be directed to Akorn's Customer Service department at 800.932.5676.


Don't have Adobe Acrobat or Adobe Reader? DOWNLOAD IT HERE

© Akorn, Inc. Lake Forest, Illinois, USA.

This web site is intended for informational purposes only and not intended to replace discussion with a healthcare provider.

If you have any questions regarding the content of this site please contact Akorn.